# Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease

> **NCT05130294** · NA · WITHDRAWN · sponsor: **Hofseth Biocare ASA**

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DIETARY_SUPPLEMENT:** CARDIO®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05130294
- **Lead sponsor:** Hofseth Biocare ASA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-07
- **Primary completion:** 2026-11
- **Final completion:** 2027-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated before recruitment began due to administrative decision.
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05130294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05130294, "Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05130294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*